DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ advanced 2.75% to $8.98 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.07% to 25,820.14 and the Dow Jones Industrial Average rising 0.59% to 52,182.74.
This was the stock's third consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 56.32% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 2.16% to $6.14, Fortress Biotech Inc. (FBIO) rose 6.88% to $2.95, and Viking Therapeutics Inc. (VKTX) rose 3.94% to $39.54.
Trading volume (416,806) remained 116,144 below its 50-day average volume of 532,950.
Data source: Dow Jones Market Data, FactSet. Data compiled June 29, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 29, 2026 17:21 ET (21:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments